Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
105,670,220
-
Number of holders
-
171
-
Total 13F shares, excl. options
-
52,505,739
-
Shares change
-
-32,392
-
Total reported value, excl. options
-
$1,373,608,654
-
Value change
-
-$54,087
-
Put/Call ratio
-
108%
-
Number of buys
-
99
-
Number of sells
-
-61
-
Price
-
$26.16
Significant Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q3 2022
196 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q3 2022.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52,505,739 shares
of 105,670,220 outstanding shares and own 50% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8,928,228 shares), VANGUARD GROUP INC (4,457,184 shares), STATE STREET CORP (4,142,060 shares), PFM Health Sciences, LP (3,383,233 shares), FMR LLC (3,355,248 shares), BVF INC/IL (2,717,020 shares), Octagon Capital Advisors LP (2,668,316 shares), Invus Financial Advisors, LLC (1,612,077 shares), PICTET ASSET MANAGEMENT SA (1,489,443 shares), and BOXER CAPITAL, LLC (1,432,200 shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.